531015 — Venmax Drugs and Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹202.77m
- IN₹177.61m
- IN₹8.07m
- 25
- 11
- 82
- 30
Annual cashflow statement for Venmax Drugs and Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -1.62 | 18.5 | 2.26 | 0.869 | -0.141 |
| Depreciation | |||||
| Non-Cash Items | — | — | — | — | 0.189 |
| Unusual Items | |||||
| Changes in Working Capital | 4.15 | 0.494 | -2.37 | -0.919 | -23 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 2.64 | 19.1 | -0.031 | 0.022 | -22.9 |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 |
| Purchase of Fixed Assets | |||||
| Cash from Investing Activities | 0 | 0 | 0 | 0 | 0 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -1.9 | -19.8 | 0.031 | 0 | 47.7 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.739 | -0.749 | 0 | 0.022 | 24.8 |